Filed: 8/14/2026ACC: 0001999371-26-018014
📋 What this filing means
FIRST LIGHT ASSET MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $1.65B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$1.65B
Total AUM (reported)
81.14M
Total Shares
Allocation by class
COMMON STOCKS$1.65B100.0%
Portfolio Concentration
Top 3$438.75M26.7%
4–10$560.60M34.1%
11–25$553.85M33.7%
Rest$92.07M5.6%
Top 3 weight
26.7%
Top 10 weight
60.7%
Voting Authority Distribution
Total shares with voting rights: 81.14M
Sole
Full voting authority
81.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
NEOGENOMICS INC
SOLEShares12.28M
TypeSH
Market value$179.16M
10.89%
Sole
12.28M
Shared
0.00
None
0.00
SI-BONE INC
SOLEShares8.13M
TypeSH
Market value$132.65M
8.06%
Sole
8.13M
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares2.75M
TypeSH
Market value$126.95M
7.72%
Sole
2.75M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares930.29K
TypeSH
Market value$123.48M
7.50%
Sole
930.29K
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC
SOLEShares771.90K
TypeSH
Market value$117.96M
7.17%
Sole
771.90K
Shared
0.00
None
0.00
TWIST BIOSCIENCE CORPORATION
SOLEShares727.93K
TypeSH
Market value$74.89M
4.55%
Sole
727.93K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares1.36M
TypeSH
Market value$69.06M
4.20%
Sole
1.36M
Shared
0.00
None
0.00
GUARDANT HEALTH
SOLEShares441.59K
TypeSH
Market value$66.25M
4.03%
Sole
441.59K
Shared
0.00
None
0.00
908 DEVICES INC
SOLEShares6.28M
TypeSH
Market value$54.66M
3.32%
Sole
6.28M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares3.02M
TypeSH
Market value$54.30M
3.30%
Sole
3.02M
Shared
0.00
None
0.00
GENEDX HOLDINGS CORP
SOLEShares783.92K
TypeSH
Market value$53.82M
3.27%
Sole
783.92K
Shared
0.00
None
0.00
SIMULATIONS PLUS INC
SOLEShares2.79M
TypeSH
Market value$51.13M
3.11%
Sole
2.79M
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares3.38M
TypeSH
Market value$51.06M
3.10%
Sole
3.38M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS INC
SOLEShares1.36M
TypeSH
Market value$50.92M
3.10%
Sole
1.36M
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.86M
TypeSH
Market value$45.46M
2.76%
Sole
2.86M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares1.10M
TypeSH
Market value$44.50M
2.70%
Sole
1.10M
Shared
0.00
None
0.00
ANAPTYS BIO INC
SOLEShares582K
TypeSH
Market value$39.29M
2.39%
Sole
582K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.10M
TypeSH
Market value$39.11M
2.38%
Sole
2.10M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares963.26K
TypeSH
Market value$32.26M
1.96%
Sole
963.26K
Shared
0.00
None
0.00
TRISALUS LIFE SCIENCES INC
SOLEShares6.55M
TypeSH
Market value$29.81M
1.81%
Sole
6.55M
Shared
0.00
None
0.00
TECTONIC THERAPEUTICS INC
SOLEShares800.73K
TypeSH
Market value$27.52M
1.67%
Sole
800.73K
Shared
0.00
None
0.00
HEALTH CATALYST INC
SOLEShares12.81M
TypeSH
Market value$25.49M
1.55%
Sole
12.81M
Shared
0.00
None
0.00
BUTTERFLY NETWORK INC
SOLEShares2.64M
TypeSH
Market value$22.25M
1.35%
Sole
2.64M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HOLDINGS
SOLEShares246.58K
TypeSH
Market value$21.16M
1.29%
Sole
246.58K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares345.16K
TypeSH
Market value$20.06M
1.22%
Sole
345.16K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEOGENOMICS INCSOLE | Common Stocks | 12.28M | SH | $179.16M 10.89% | 12.28M | 0.00 | 0.00 |
SI-BONE INCSOLE | Common Stocks | 8.13M | SH | $132.65M 8.06% | 8.13M | 0.00 | 0.00 |
AXOGEN INCSOLE | Common Stocks | 2.75M | SH | $126.95M 7.72% | 2.75M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | Common Stocks | 930.29K | SH | $123.48M 7.50% | 930.29K | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INCSOLE | Common Stocks | 771.90K | SH | $117.96M 7.17% | 771.90K | 0.00 | 0.00 |
TWIST BIOSCIENCE CORPORATIONSOLE | Common Stocks | 727.93K | SH | $74.89M 4.55% | 727.93K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | Common Stocks | 1.36M | SH | $69.06M 4.20% | 1.36M | 0.00 | 0.00 |
GUARDANT HEALTHSOLE | Common Stocks | 441.59K | SH | $66.25M 4.03% | 441.59K | 0.00 | 0.00 |
908 DEVICES INCSOLE | Common Stocks | 6.28M | SH | $54.66M 3.32% | 6.28M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | Common Stocks | 3.02M | SH | $54.30M 3.30% | 3.02M | 0.00 | 0.00 |
GENEDX HOLDINGS CORPSOLE | Common Stocks | 783.92K | SH | $53.82M 3.27% | 783.92K | 0.00 | 0.00 |
SIMULATIONS PLUS INCSOLE | Common Stocks | 2.79M | SH | $51.13M 3.11% | 2.79M | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | Common Stocks | 3.38M | SH | $51.06M 3.10% | 3.38M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INCSOLE | Common Stocks | 1.36M | SH | $50.92M 3.10% | 1.36M | 0.00 | 0.00 |
NEUROPACE INCSOLE | Common Stocks | 2.86M | SH | $45.46M 2.76% | 2.86M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | Common Stocks | 1.10M | SH | $44.50M 2.70% | 1.10M | 0.00 | 0.00 |
ANAPTYS BIO INCSOLE | Common Stocks | 582K | SH | $39.29M 2.39% | 582K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | Common Stocks | 2.10M | SH | $39.11M 2.38% | 2.10M | 0.00 | 0.00 |
SEPTERNA INCSOLE | Common Stocks | 963.26K | SH | $32.26M 1.96% | 963.26K | 0.00 | 0.00 |
TRISALUS LIFE SCIENCES INCSOLE | Common Stocks | 6.55M | SH | $29.81M 1.81% | 6.55M | 0.00 | 0.00 |
TECTONIC THERAPEUTICS INCSOLE | Common Stocks | 800.73K | SH | $27.52M 1.67% | 800.73K | 0.00 | 0.00 |
HEALTH CATALYST INCSOLE | Common Stocks | 12.81M | SH | $25.49M 1.55% | 12.81M | 0.00 | 0.00 |
BUTTERFLY NETWORK INCSOLE | Common Stocks | 2.64M | SH | $22.25M 1.35% | 2.64M | 0.00 | 0.00 |
ESTABLISHMENT LABS HOLDINGSSOLE | Common Stocks | 246.58K | SH | $21.16M 1.29% | 246.58K | 0.00 | 0.00 |
VAXCYTE INCSOLE | Common Stocks | 345.16K | SH | $20.06M 1.22% | 345.16K | 0.00 | 0.00 |
Page 1 of 2